Skip to content

H.R. 4958 · 119th Congress (2025–2027)

GRAS Act

This bill imposes premarket review requirements on certain new substances intended for use in food and requires the Food and Drug Administration (FDA) to periodically reassess the safety of existing substances used in food.

Under current law, substances added to food generally must be approved by the FDA before use. However, substances that are generally recognized as safe (GRAS) by qualified experts are exempt from premarket review. Manufacturers may, but are not required to, notify the FDA when they determine a substance is GRAS.

Under the bill, a new substance (or a new use of an existing substance) may not be treated as GRAS and used in food until the FDA is notified of the determination that the substance is GRAS and issues a written statement that it does not object to that determination. The notification must detail the conditions under which the substance has been determined to be GRAS and must include specified supporting information, including evidence that the substance is not toxic or carcinogenic. The FDA must seek public comment on GRAS notifications and must act on notifications within a specified period.

Further, the FDA must regularly reassess the safety of certain substances used in food, including substances considered GRAS before the bill's enactment, and may require the submission of safety information for substances being reassessed.

Finally, the bill establishes fees for initial FDA review of substances used in food and for safety reassessments.

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to require notification to the Food and Drug Administration prior to use of substances as generally recognized as safe, reassessment of the safety of certain substances marketed as generally recognized as safe, provide resources for reviews and reassessments, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 4958’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Frank Pallone (D-NJ-6)
Cosponsors
5 cosponsors

0 original · 5 later

  1. Del. Eleanor Holmes Norton (D-DC)· Later · Dec 1, 2025
  2. Rep. Rashida Tlaib (D-MI-12)· Later · Feb 3, 2026
  3. Rep. Ro Khanna (D-CA-17)· Later · Feb 24, 2026
  4. Rep. Paul Tonko (D-NY-20)· Later · Feb 24, 2026
  5. Rep. Kim Schrier (D-WA-8)· Later · Jul 9, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Aug 12, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. GRAS Act

    Display title, Short title · Introduced in House

  2. Grocery Reform And Safety Act

    Short title · Introduced in House

  3. To amend the Federal Food, Drug, and Cosmetic Act to require notification to the Food and Drug Administration prior to use of substances as generally recognized as safe, reassessment of the safety of certain substances marketed as generally recognized as safe, provide resources for reviews and reassessments, and for other purposes.

    Official title · Introduced in House